> Search for information about Alzheimer's disease

╭────────────────────────────────────────────────────────────────────────────────────────────────────────────╮
│ ✓  OpenTargets_get_disease_id_description_by_name (tooluniverse MCP Server) {"diseaseName":"Alzheimer's d… │
│                                                                                                            │
│    ... first 71 lines hidden ...                                                                           │
│              "name": "neuritic plaque measurement",                                                        │
│              "description": "quantification of  neuritic (senile) plaques in the brain, Senile plaques     │
│    (also known as neuritic plaques, senile druse and braindruse) are extracellular deposits of amyloid     │
│    beta in the grey matter of the brain.[1][2] Degenerative neural structures and an abundance of          │
│    microglia and astrocytes can be associated with senile plaque deposits. These deposits can also be a    │
│    byproduct of senescence (ageing). However, large numbers of senile plaques and neurofibrillary tangles  │
│    are characteristic features of Alzheimer's disease. Abnormal neurites in senile plaques are composed    │
│    primarily of paired helical filaments, a component of neurofibrillary tangles.[3] The plaques are       │
│    variable in shape and size, but are on average 50 \u00b5m in size.[4] In Alzheimer's disease they are   │
│    primarily composed of amyloid beta peptides."                                                           │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0004840",                                                                          │
│              "name": "cortical thickness",                                                                 │
│              "description": "Is a quantification of the thickness of brain cortex, e.g. measured by MRI,   │
│    used in the diagnosis of Alzheimer's disease and other neurological conditions"                         │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0011057",                                                                          │
│              "name": "neurotoxicity",                                                                      │
│              "description": "Toxicity that causes injury to the central or peripheral nervous system or    │
│    damages its function. This can include stroke, multiple sclerosis, encephalopathy, dementia,            │
│    Alzheimer's disease, amnesia, dyskinesia, Parkinson's disease, tremor, convulsions and Guillain Barre   │
│    syndrome. "                                                                                             │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0007646",                                                                          │
│              "name": "amyloid plaque accumulation rate",                                                   │
│              "description": "quantification of accumulation of amyloid plaques in the brain over a long    │
│    period of time (typically several years), measured by using PET scan imaging technology. The            │
│    accumulation of amyloid plaques can be a biomarker for Alzheimer's disease"                             │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0004874",                                                                          │
│              "name": "memory performance",                                                                 │
│              "description": "Is a quantification of a subject's activities involved in the mental          │
│    information processing system that receives (registers), modifies, stores, and retrieves informational  │
│    stimuli. Memory performance is typically assessed by some clinical memory test and is used in the       │
│    diagnosis of diseases such as Alzheimer's disease."                                                     │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0010151",                                                                          │
│              "name": "soluble triggering receptor expressed on myeloid cells 2 measurement",               │
│              "description": "Quantification of the amount of soluble TREM2 (triggering receptor expressed  │
│    on myeloid cells 2) protein in a sample. Cerebrospinal fluid sTREM2 is used as a biomarker of disease   │
│    pathogenesis in Alzheimer's disease."                                                                   │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0004670",                                                                          │
│              "name": "beta-amyloid 1-42 measurement",                                                      │
│              "description": "Is the quantification of Beta-amyloid 1-42 in cerebrospinal fluid typically   │
│    used as a biomarker for Alzheimer's Disease"                                                            │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0004760",                                                                          │
│              "name": "t-tau measurement",                                                                  │
│              "description": "Is a quantification of total tau protein, a biomarker for Alzheimer's         │
│    disease."                                                                                               │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0005194",                                                                          │
│              "name": "amyloid-beta measurement",                                                           │
│              "description": "quantification of the amyloid-beta, either in a sample of cerebro-spinal      │
│    fluid or via PET scan, used as a biomarker for Alzheimer's disease"                                     │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0005660",                                                                          │
│              "name": "plasma beta-amyloid 1-42 measurement",                                               │
│              "description": "Is the quantification of Beta-amyloid 1-42 in plasma, typically used as a     │
│    biomarker for Alzheimer's Disease"                                                                      │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0000699",                                                                          │
│              "name": "Sjogren syndrome",                                                                   │
│              "description": "Chronic inflammatory and autoimmune disease in which the salivary and         │
│    lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased  │
│    production of saliva and tears. The primary form, often called sicca syndrome, involves both            │
│    KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a  │
│    connective tissue disease, usually rheumatoid arthritis."                                               │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0007710",                                                                          │
│              "name": "cognitive decline measurement",                                                      │
│              "description": "quantification of some aspect of cognitive decline such as the rate at which  │
│    it occurs or its severity, for example in patients with dementia or Alzheimer's disease. Cognitive      │
│    decline is ususally assessed using a structured-interview protocol covering a number of standardised    │
│    areas."                                                                                                 │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0004763",                                                                          │
│              "name": "p-tau measurement",                                                                  │
│              "description": "Is a quantification of phosphorylated tau protein, used as a biomarker for    │
│    Alzheimer's disease."                                                                                   │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "EFO_0009179",                                                                          │
│              "name": "beta-secretase 1 measurement",                                                       │
│              "description": "Quantification of the amount of beta-secretase 1 in a sample, typicallly      │
│    cerebrospinal fluid. Beta-secretase-1 is an aspartic-acid protease important in the formation of myelin │
│    sheaths in peripheral nerve cells, and is thought to have a role in Alzheimer's disease pathogenesis."  │
│            },                                                                                              │
│            {                                                                                               │
│              "id": "MONDO_0024625",                                                                        │
│              "name": "disorder of lacrimal gland",                                                         │
│              "description": "A disease that involves the lacrimal gland."                                  │
│            }                                                                                               │
│          ]                                                                                                 │
│        }                                                                                                   │
│      }                                                                                                     │
│    }                                                                                                       │
╰────────────────────────────────────────────────────────────────────────────────────────────────────────────╯
╭────────────────────────────────────────────────────────────────────────────────────────────────────────────╮
│ ✓  OpenTargets_get_associated_targets_by_disease_efoId (tooluniverse MCP Server) {"efoId":"MONDO_0004975"} │
│                                                                                                            │
│    ... first 78 lines hidden ...                                                                           │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000114200",                                                                  │
│                  "approvedSymbol": "BCHE"                                                                  │
│                },                                                                                          │
│                "score": 0.620249600375919                                                                  │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000159640",                                                                  │
│                  "approvedSymbol": "ACE"                                                                   │
│                },                                                                                          │
│                "score": 0.6176415201304783                                                                 │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000273079",                                                                  │
│                  "approvedSymbol": "GRIN2B"                                                                │
│                },                                                                                          │
│                "score": 0.6097120570955326                                                                 │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000176749",                                                                  │
│                  "approvedSymbol": "CDK5R1"                                                                │
│                },                                                                                          │
│                "score": 0.6074644588169549                                                                 │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000010704",                                                                  │
│                  "approvedSymbol": "HFE"                                                                   │
│                },                                                                                          │
│                "score": 0.604313672707205                                                                  │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000101224",                                                                  │
│                  "approvedSymbol": "CDC25B"                                                                │
│                },                                                                                          │
│                "score": 0.598527591199878                                                                  │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000105464",                                                                  │
│                  "approvedSymbol": "GRIN2D"                                                                │
│                },                                                                                          │
│                "score": 0.597221951945006                                                                  │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000183454",                                                                  │
│                  "approvedSymbol": "GRIN2A"                                                                │
│                },                                                                                          │
│                "score": 0.5966500414884671                                                                 │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000138613",                                                                  │
│                  "approvedSymbol": "APH1B"                                                                 │
│                },                                                                                          │
│                "score": 0.5964544517246868                                                                 │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000198785",                                                                  │
│                  "approvedSymbol": "GRIN3A"                                                                │
│                },                                                                                          │
│                "score": 0.5921984662871365                                                                 │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000161509",                                                                  │
│                  "approvedSymbol": "GRIN2C"                                                                │
│                },                                                                                          │
│                "score": 0.5919963523636346                                                                 │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000030582",                                                                  │
│                  "approvedSymbol": "GRN"                                                                   │
│                },                                                                                          │
│                "score": 0.5896728389078704                                                                 │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000116032",                                                                  │
│                  "approvedSymbol": "GRIN3B"                                                                │
│                },                                                                                          │
│                "score": 0.5892712489835275                                                                 │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000146904",                                                                  │
│                  "approvedSymbol": "EPHA1"                                                                 │
│                },                                                                                          │
│                "score": 0.5888571721590647                                                                 │
│              },                                                                                            │
│              {                                                                                             │
│                "target": {                                                                                 │
│                  "id": "ENSG00000113161",                                                                  │
│                  "approvedSymbol": "HMGCR"                                                                 │
│                },                                                                                          │
│                "score": 0.5865220090871499                                                                 │
│              }                                                                                             │
│            ]                                                                                               │
│          }                                                                                                 │
│        }                                                                                                   │
│      }                                                                                                     │
│    }                                                                                                       │
╰────────────────────────────────────────────────────────────────────────────────────────────────────────────╯
╭────────────────────────────────────────────────────────────────────────────────────────────────────────────╮
│ ✓  OpenTargets_get_associated_drugs_by_disease_efoId (tooluniverse MCP Server) {"efoId":"MONDO_0004975","… │
│                                                                                                            │
│    ... first 13427 lines hidden ...                                                                        │
│                  "tradeNames": [                                                                           │
│                    "Marplan"                                                                               │
│                  ],                                                                                        │
│                  "maximumClinicalTrialPhase": 4,                                                           │
│                  "isApproved": true,                                                                       │
│                  "hasBeenWithdrawn": false                                                                 │
│                },                                                                                          │
│                "phase": 0.5,                                                                               │
│                "status": "Completed",                                                                      │
│                "mechanismOfAction": "Monoamine oxidase inhibitor",                                         │
│                "target": {                                                                                 │
│                  "id": "ENSG00000069535",                                                                  │
│                  "approvedSymbol": "MAOB"                                                                  │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "drug": {                                                                                   │
│                  "id": "CHEMBL1201168",                                                                    │
│                  "name": "ISOCARBOXAZID",                                                                  │
│                  "tradeNames": [                                                                           │
│                    "Marplan"                                                                               │
│                  ],                                                                                        │
│                  "maximumClinicalTrialPhase": 4,                                                           │
│                  "isApproved": true,                                                                       │
│                  "hasBeenWithdrawn": false                                                                 │
│                },                                                                                          │
│                "phase": 0.5,                                                                               │
│                "status": "Completed",                                                                      │
│                "mechanismOfAction": "Monoamine oxidase inhibitor",                                         │
│                "target": {                                                                                 │
│                  "id": "ENSG00000189221",                                                                  │
│                  "approvedSymbol": "MAOA"                                                                  │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "drug": {                                                                                   │
│                  "id": "CHEMBL10316",                                                                      │
│                  "name": "IDAZOXAN",                                                                       │
│                  "maximumClinicalTrialPhase": 3,                                                           │
│                  "isApproved": false,                                                                      │
│                  "hasBeenWithdrawn": false                                                                 │
│                },                                                                                          │
│                "phase": 0.5,                                                                               │
│                "status": "Completed",                                                                      │
│                "mechanismOfAction": "Adrenergic receptor alpha-2 antagonist",                              │
│                "target": {                                                                                 │
│                  "id": "ENSG00000150594",                                                                  │
│                  "approvedSymbol": "ADRA2A"                                                                │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "drug": {                                                                                   │
│                  "id": "CHEMBL10316",                                                                      │
│                  "name": "IDAZOXAN",                                                                       │
│                  "maximumClinicalTrialPhase": 3,                                                           │
│                  "isApproved": false,                                                                      │
│                  "hasBeenWithdrawn": false                                                                 │
│                },                                                                                          │
│                "phase": 0.5,                                                                               │
│                "status": "Completed",                                                                      │
│                "mechanismOfAction": "Adrenergic receptor alpha-2 antagonist",                              │
│                "target": {                                                                                 │
│                  "id": "ENSG00000274286",                                                                  │
│                  "approvedSymbol": "ADRA2B"                                                                │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "drug": {                                                                                   │
│                  "id": "CHEMBL10316",                                                                      │
│                  "name": "IDAZOXAN",                                                                       │
│                  "maximumClinicalTrialPhase": 3,                                                           │
│                  "isApproved": false,                                                                      │
│                  "hasBeenWithdrawn": false                                                                 │
│                },                                                                                          │
│                "phase": 0.5,                                                                               │
│                "status": "Terminated",                                                                     │
│                "mechanismOfAction": "Adrenergic receptor alpha-2 antagonist",                              │
│                "target": {                                                                                 │
│                  "id": "ENSG00000274286",                                                                  │
│                  "approvedSymbol": "ADRA2B"                                                                │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "drug": {                                                                                   │
│                  "id": "CHEMBL109",                                                                        │
│                  "name": "VALPROIC ACID",                                                                  │
│                  "tradeNames": [                                                                           │
│                    "Convulex",                                                                             │
│                    "Depakene",                                                                             │
│                    "Depakote",                                                                             │
│                    "Stavzor",                                                                              │
│                    "Valproic acid"                                                                         │
│                  ],                                                                                        │
│                  "maximumClinicalTrialPhase": 4,                                                           │
│                  "isApproved": true,                                                                       │
│                  "hasBeenWithdrawn": false                                                                 │
│                },                                                                                          │
│                "phase": 0.5,                                                                               │
│                "status": "Completed",                                                                      │
│                "mechanismOfAction": "Succinate semialdehyde dehydrogenase inhibitor",                      │
│                "target": {                                                                                 │
│                  "id": "ENSG00000112294",                                                                  │
│                  "approvedSymbol": "ALDH5A1"                                                               │
│                }                                                                                           │
│              }                                                                                             │
│            ]                                                                                               │
│          }                                                                                                 │
│        }                                                                                                   │
│      }                                                                                                     │
│    }                                                                                                       │
╰────────────────────────────────────────────────────────────────────────────────────────────────────────────╯
╭────────────────────────────────────────────────────────────────────────────────────────────────────────────╮
│ ✓  OpenTargets_get_associated_phenotypes_by_disease_efoId (tooluniverse MCP Server) {"efoId":"MONDO_00049… │
│                                                                                                            │
│    ... first 69 lines hidden ...                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "phenotypeHPO": {                                                                           │
│                  "id": "HP_0002423",                                                                       │
│                  "name": "Long-tract sign",                                                                │
│                  "description": "Long-tract signs refer to symptoms that are attributable to the           │
│    involvement of the long fiber tracts in the spinal cord, which connect the spinal cord to the brain and │
│    mediate spinal and motor functions. These include spasticity, hyperreflexia, and abnormal reflexes such │
│    as Babinski or Hoffman's sign. If possible, it is preferable to use the precise HPO terms for these     │
│    abnormalities."                                                                                         │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "phenotypeHPO": {                                                                           │
│                  "id": "HP_0001300",                                                                       │
│                  "name": "Parkinsonism",                                                                   │
│                  "description": "Characteristic neurologic anomaly resulting from degeneration of          │
│    dopamine-generating cells in the substantia nigra, a region of the midbrain, characterized clinically   │
│    by shaking, rigidity, slowness of movement and difficulty with walking and gait."                       │
│                },                                                                                          │
│                "phenotypeEFO": {                                                                           │
│                  "id": "HP_0001300",                                                                       │
│                  "name": "Parkinsonism"                                                                    │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "phenotypeHPO": {                                                                           │
│                  "id": "HP_0002185",                                                                       │
│                  "name": "Neurofibrillary tangles",                                                        │
│                  "description": "Pathological protein aggregates formed by hyperphosphorylation of a       │
│    microtubule-associated protein known as tau, causing it to aggregate in an insoluble form."             │
│                },                                                                                          │
│                "phenotypeEFO": {                                                                           │
│                  "id": "HP_0002185",                                                                       │
│                  "name": "Neurofibrillary tangles"                                                         │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "phenotypeHPO": {                                                                           │
│                  "id": "HP_0003584",                                                                       │
│                  "name": "Late onset",                                                                     │
│                  "description": "A type of adult onset with onset of symptoms after the age of 60 years."  │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "phenotypeHPO": {                                                                           │
│                  "id": "HP_0002511",                                                                       │
│                  "name": "Alzheimer disease",                                                              │
│                  "description": "A degenerative disease of the brain characterized by the insidious onset  │
│    of dementia. Impairment of memory, judgment, attention span, and problem solving skills are followed by │
│    severe apraxia and a global loss of cognitive abilities. The condition primarily occurs after age 60,   │
│    and is marked pathologically by severe cortical atrophy and the triad of senile plaques,                │
│    neurofibrillary tangles, and neuropil threads."                                                         │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "phenotypeHPO": {                                                                           │
│                  "id": "HP_0410170",                                                                       │
│                  "name": "Hippocampal atrophy",                                                            │
│                  "description": "Partial or complete wasting (loss) of hippocampus tissue that was once    │
│    present."                                                                                               │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "phenotypeHPO": {                                                                           │
│                  "id": "HP_0003581",                                                                       │
│                  "name": "Adult onset",                                                                    │
│                  "description": "Onset of disease manifestations in adulthood, defined here as at the age  │
│    of 16 years or later."                                                                                  │
│                },                                                                                          │
│                "phenotypeEFO": {                                                                           │
│                  "id": "HP_0003581",                                                                       │
│                  "name": "Adult onset"                                                                     │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "phenotypeHPO": {                                                                           │
│                  "id": "HP_0002120",                                                                       │
│                  "name": "Cerebral cortical atrophy",                                                      │
│                  "description": "Atrophy of the cortex of the cerebrum."                                   │
│                },                                                                                          │
│                "phenotypeEFO": {                                                                           │
│                  "id": "HP_0002120",                                                                       │
│                  "name": "Cerebral cortical atrophy"                                                       │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "phenotypeHPO": {                                                                           │
│                  "id": "HP_0000716",                                                                       │
│                  "name": "Depression",                                                                     │
│                  "description": "Frequently experiencing feelings of being down, miserable, and/or         │
│    hopeless; struggling to recover from these moods; having a pessimistic outlook on the future; feeling a │
│    pervasive sense of shame; having a low self-worth; experiencing thoughts of suicide and engaging in     │
│    suicidal behavior."                                                                                     │
│                }                                                                                           │
│              },                                                                                            │
│              {                                                                                             │
│                "phenotypeHPO": {                                                                           │
│                  "id": "HP_0000734",                                                                       │
│                  "name": "Disinhibition",                                                                  │
│                  "description": "Reduced ability to control, or a failure to resist a temptation, urge, or │
│    impulse. Examples include disregard for social conventions, general impulsivity, and poor risk          │
│    assessment."                                                                                            │
│                }                                                                                           │
│              }                                                                                             │
│            ]                                                                                               │
│          }                                                                                                 │
│        }                                                                                                   │
│      }                                                                                                     │
│    }                                                                                                       │
╰────────────────────────────────────────────────────────────────────────────────────────────────────────────╯
╭────────────────────────────────────────────────────────────────────────────────────────────────────────────╮
│ ✓  EuropePMC_search_articles (tooluniverse MCP Server) {"limit":10,"query":"Alzheimer's disease"}          │
│                                                                                                            │
│    ... first 410 lines hidden ...                                                                          │
│        }                                                                                                   │
│      },                                                                                                    │
│      {                                                                                                     │
│        "title": "Neural flexibility is higher in Alzheimer's disease and predicts Alzheimer's disease      │
│    transition.",                                                                                           │
│        "abstract": "BackgroundNeural flexibility (NF), a measure of dynamic functional connectivity, was   │
│    associated with psychiatric diseases but has not yet been studied in Alzheimer's disease                │
│    (AD).ObjectiveWe aim to evaluate whether AD is associated with alterations in NF and probe its          │
│    predictive utility for AD conversion.MethodThe study included 862 older adults (461 cognitively normal  │
│    (CN), 294 mild cognitive impairment (MCI), 107 AD) with valid resting-state fMRI data from the          │
│    Alzheimer's Disease Neuroimaging Initiative. We defined the NF of a node as the number of times that a  │
│    node changed its community assignment across the sliding windows, normalized by the total number of     │
│    possible changes. We computed global NF and 12 functional network-specific NFs, then performed linear   │
│    mixed models on NFs separately to explore the differences in these measures between our three groups.   │
│    Finally, we evaluated the predictive utility of NF on dementia transition using survival                │
│    analysis.ResultsNF is significantly higher in AD than CN on global NF (\u03b2\u2009=\u20090.002, 95% CI │
│    0.001 to 0.004), and NF in six networks, and NF is significantly higher in MCI than CN in the visual    │
│    network. Among n\u2009=\u2009617 non-demented participants at baseline, n\u2009=\u200953 (8.6%)         │
│    participants converted to dementia during the follow-up visits. Higher NF in the visual network was     │
│    positively associated with AD transition (HR\u2009=\u20091.323, 95%CI 1.002 to 1.747,                   │
│    p\u2009=\u20090.049, per 1 SD in NF), controlling for age, gender, and education.ConclusionsWe found    │
│    that NF during rest was higher in AD patients and predicted dementia transition. Thus, NF may be a      │
│    valuable biomarker of AD; however, more validation and mechanistic studies need to be performed.",      │
│        "authors": [                                                                                        │
│          "Varangis E",                                                                                     │
│          "Liu J",                                                                                          │
│          "Miao Y",                                                                                         │
│          "Zhu X",                                                                                          │
│          "Stern Y",                                                                                        │
│          "Lee S"                                                                                           │
│        ],                                                                                                  │
│        "journal": "J Alzheimers Dis",                                                                      │
│        "year": "2025",                                                                                     │
│        "doi": "10.1177/13872877251360025",                                                                 │
│        "url": "https://europepmc.org/article/MED/40671553",                                                │
│        "citations": 0,                                                                                     │
│        "open_access": "N",                                                                                 │
│        "keywords": "Keywords not available",                                                               │
│        "source": "Europe PMC",                                                                             │
│        "data_quality": {                                                                                   │
│          "has_abstract": true,                                                                             │
│          "has_authors": true,                                                                              │
│          "has_journal": true,                                                                              │
│          "has_year": true,                                                                                 │
│          "has_doi": true,                                                                                  │
│          "has_citations": false,                                                                           │
│          "has_keywords": false,                                                                            │
│          "has_url": true                                                                                   │
│        }                                                                                                   │
│      }                                                                                                     │
│    ]                                                                                                       │
│                                                                                                            │
│ ✓  PubMed_search_articles (tooluniverse MCP Server) {"query":"Alzheimer's disease","limit":10}             │
│                                                                                                            │
│    ... first 302 lines hidden ...                                                                          │
│        ],                                                                                                  │
│        "journal": "Journal of neurology, neurosurgery, and psychiatry",                                    │
│        "year": 2025,                                                                                       │
│        "doi": "10.1136/jnnp-2025-336805",                                                                  │
│        "url": "https://pubmed.ncbi.nlm.nih.gov/41188051/",                                                 │
│        "citations": 0,                                                                                     │
│        "open_access": false,                                                                               │
│        "keywords": "Keywords not available",                                                               │
│        "article_type": "Journal Article",                                                                  │
│        "source": "PubMed",                                                                                 │
│        "data_quality": {                                                                                   │
│          "has_abstract": false,                                                                            │
│          "has_authors": true,                                                                              │
│          "has_journal": true,                                                                              │
│          "has_year": true,                                                                                 │
│          "has_doi": true,                                                                                  │
│          "has_citations": false,                                                                           │
│          "has_keywords": false,                                                                            │
│          "has_url": true                                                                                   │
│        }                                                                                                   │
│      },                                                                                                    │
│      {                                                                                                     │
│        "title": "Targeting the C5-C5aR1 Axis: A promising therapeutic strategy for Alzheimer's disease and │
│    amyotrophic lateral sclerosis by Unlocking Neuroprotection.",                                           │
│        "abstract": "Abstract not available",                                                               │
│        "authors": [                                                                                        │
│          "Ge TQ",                                                                                          │
│          "Wang P",                                                                                         │
│          "Guan PP"                                                                                         │
│        ],                                                                                                  │
│        "journal": "Biochemical pharmacology",                                                              │
│        "year": 2025,                                                                                       │
│        "doi": "10.1016/j.bcp.2025.117518",                                                                 │
│        "url": "https://pubmed.ncbi.nlm.nih.gov/41187881/",                                                 │
│        "citations": 0,                                                                                     │
│        "open_access": false,                                                                               │
│        "keywords": "Keywords not available",                                                               │
│        "article_type": "Journal Article",                                                                  │
│        "source": "PubMed",                                                                                 │
│        "data_quality": {                                                                                   │
│          "has_abstract": false,                                                                            │
│          "has_authors": true,                                                                              │
│          "has_journal": true,                                                                              │
│          "has_year": true,                                                                                 │
│          "has_doi": true,                                                                                  │
│          "has_citations": false,                                                                           │
│          "has_keywords": false,                                                                            │
│          "has_url": true                                                                                   │
│        }                                                                                                   │
│      }                                                                                                     │
│    ]                                                                                                       │
╰────────────────────────────────────────────────────────────────────────────────────────────────────────────╯
✦ I have gathered comprehensive information about Alzheimer's disease.

  Disease Identification:
   * EFO ID: MONDO_0004975
   * Name: Alzheimer disease
   * Description: A progressive, neurodegenerative disease characterized by loss of function and death of nerve
     cells in several areas of the brain leading to loss of cognitive function such as memory and language.

  Associated Targets:
  There are 12874 associated targets. Some of the top targets include:
   * PSEN1 (ENSG00000080815)
   * APP (ENSG00000142192)
   * PSEN2 (ENSG00000143801)
   * APOE (ENSG00000130203)
   * SORL1 (ENSG00000137642)
   * GRIN1 (ENSG00000176884)
   * CDK5 (ENSG00000164885)
   * ADAM10 (ENSG00000137845)
   * ABCA7 (ENSG00000064687)
   * ACHE (ENSG00000087085)

  Associated Drugs:
  There are 673 associated drugs. Some notable examples include:
   * DONEPEZIL HYDROCHLORIDE (CHEMBL1678): Approved, Phase 4, Acetylcholinesterase inhibitor, targets ACHE.
   * MEMANTINE HYDROCHLORIDE (CHEMBL1699): Approved, Phase 4, Glutamate [NMDA] receptor negative allosteric
     modulator, targets GRIN2D, GRIN2C, GRIN1, GRIN3A.
   * ADUCANUMAB (CHEMBL3039540): Approved, Phase 4, Beta amyloid A4 protein binding agent, targets APP.
   * LECANEMAB (CHEMBL3833321): Approved, Phase 4, Beta amyloid A4 protein inhibitor, targets APP.
   * RIVASTIGMINE (CHEMBL636): Approved, Phase 4, Cholinesterases; ACHE & BCHE inhibitor, targets BCHE, ACHE.
   * GALANTAMINE HYDROBROMIDE (CHEMBL1555): Approved, Phase 4, Acetylcholinesterase inhibitor, targets ACHE.
   * SOLANEZUMAB (CHEMBL1743072): Not approved, Phase 3, Beta amyloid A4 protein binding agent, targets APP.
   * DONANEMAB (CHEMBL4297245): Not approved, Phase 3, Beta amyloid A4 protein disrupting agent, targets APP.

  Associated Phenotypes:
  Key phenotypes associated with Alzheimer's disease include:
   * Autosomal dominant inheritance (HP_0000006)
   * Abnormality of extrapyramidal motor function (HP_0002071)
   * Dementia (HP_0000726)
   * Senile plaques (HP_0100256)
   * Memory impairment (HP_0002354)
   * Decreased circulating GABA concentration (HP_0410054)
   * Long-tract sign (HP_0002423)
   * Parkinsonism (HP_0001300)
   * Neurofibrillary tangles (HP_0002185)
   * Late onset (HP_0003584)
   * Hippocampal atrophy (HP_0410170)
   * Adult onset (HP_0003581)
   * Cerebral cortical atrophy (HP_0002120)
   * Depression (HP_0000716)
   * Disinhibition (HP_0000734)

  Recent Literature:
  Several recent articles (from 2025 and 2026) were found, covering topics such as:
   * Treatment strategies for Alzheimer's disease, including pharmacological and non-pharmacological approaches,
     and the integration of anti-β amyloid monoclonal antibodies.
   * Pathophysiology of Alzheimer's disease, focusing on amyloid-beta plaques, tau tangles, neuron loss, genetic
     mutations, mitochondrial dysfunction, inflammation, oxidative stress, and metal imbalances.
   * The role of brain cellular senescence and its interaction with Alzheimer's disease pathology.
   * The dualistic roles of astrocytes and microglia in AD pathogenesis, highlighting their contributions to
     pathology, synapse loss, demyelination, and neuroinflammation.
   * New blood biomarkers for Alzheimer's disease.
   * The mechanisms of cuproptosis and its links with Alzheimer's disease, suggesting copper overload as a
     factor in neuronal loss.
   * Neural flexibility as a potential biomarker for AD and its prediction of dementia conversion.
   * Gene module-trait network analysis uncovering cell type specific systems and genes relevant to Alzheimer's
     Disease.
   * Comparative safety of cholinesterase inhibitors and memantine for dementia.
   * Mitochondrial complex III-derived ROS amplifying immunometabolic changes in astrocytes and promoting
     dementia pathology.
   * Evaluation of neuroprotective potential of intranasal polydopamine nanoparticles in a rat model for
     Alzheimer's disease.
   * Longitudinal functional connectivity related to Alzheimer's pathology and episodic memory.
   * Survival and mortality rates in early onset dementia.
   * Targeting the C5-C5aR1 Axis for neuroprotection in Alzheimer's disease.